Recent Publications:

BREAST CANCER

Duffy MJ, Mullooly M, O’Donovan N, Sukor S, Crown J, Pierce A, McGowan PM. The ADAMS family of proteases: new biomarkers and therapeutic targets for cancer. Clin Proteomics.  2011 Jun 9;8(1);9 PMID: 21906355

Tryfonopoulos D, Walsh S, Collins DM, Flanagan L, Quinn C, Corkery B, McDermott EW, Evoy D, Pierce A, O’Donovan N, Crown J, Duffy MJ. Src: a potential target for the treatment of triple-negative breast cancer. Ann Oncol 2001 Oct;22(10):2234-40 PMID 21357651

Corcoran C, Friel AM, Duffy MJ, Crown J, O’Driscoll L. Intracellular and extracellular microRNSs in breast cancer. Clin Chem 2001 Jan;57(1):18-32 PMID 21059829

Walsh S, Flanagan L, Quinn C, Evoy D, McDermott EW, Pierce A, Duffy MJ. mTOR in breast cancer: Differential expression in triple-negative and non-triple-negative tumors. Breast 2011 Sept 28 PMID: 21963359

Sturgeon CM, Duffy MJ, Walker G. The National Institute for Health and clinical excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory. Ann Clin Biochem 2011 Jul;48(Pt4):295-9 PMID 21746796

Browne BC, Crown J, Venkatesan N, Duffy MJ, Clynes M, Slamon D, O’Donovan N. Inhibition of IGFIR activity enhances response to trastuzumab in HER-2-positive breast cancer cells. Ann Oncol 2011 Jan;22(1):68-73. PMID 20647220.

Duffy MJ, O’Donovan N, Crown J. Use of molecular markers for predicting therapy response in cancer patients. Cancer Treat Rev. 2011 Apr;37(2):151-9. PMID 20685042

Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, Nicolini A. Haglund C, Holubec L, Fraser CG, Halloran SP. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011 Jan 1;128(1)3-11. PMID 20824704.

Duffy MJ. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening? Ann Clin Biochem 2011 Apr 27. PMID 21525152.

McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of S100 genes in breast cancer progression. Tumour Biol 2011 Jun;32(3):441-50. PMID 21153724